Next-generation Solution for Pain Management Receives CE Mark
Spinal Modulation has received the CE Mark, indicating the system may be used in the management of chronic, intractable pain. The therapy uses low-level electrical signals to modulate neural structures within the dorsal root ganglion (DRG).
NANS Presentations Suggest Promising Results of Dorsal Root Ganglion Stimulation
Initial results of the multicenter, prospective clinical trial to assess the performance of the Spinal Modulation™ Neurostimulator System in the treatment of chronic pain were presented during the 15th Annual NANS Conference in Las Vegas on Sunday, December 11, 2011.
The presentation was given by Dr. Liong Liem, Director of the Pain Management Practice at Sint Antonius Hospital in The Netherlands, and Dr. Paul Verrills, Co-director of the Metro Spine Clinic in Melbourne, Australia.